Literature DB >> 19664144

Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency.

D A Fulcher1, D T Avery, N L Fewings, L J Berglund, S Wong, D S Riminton, S Adelstein, S G Tangye.   

Abstract

Common variable immunodeficiency (CVID) is a B cell immunodeficiency disorder characterized frequently by failure of memory B cell development and antibody secretion. A unifying cellular pathogenesis for CVID has not been forthcoming, but given the immunoregulatory role of invariant NK (iNK) T cells and their absence in several other immunodeficiencies, we quantified these cells in the blood of 58 CVID patients. There was a marked decrease in the proportion of iNK T cells in CVID patients compared with controls. This was particularly notable in those with low isotype-switched memory B cells, but subset analysis demonstrated no difference when stratified by specific clinical features. We propose that the decreased proportion of iNK T cells in CVID might be linked to the failure of memory B cell generation, which may contribute to reduced antibody production in these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19664144      PMCID: PMC2745030          DOI: 10.1111/j.1365-2249.2009.03973.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Innate immune responses support adaptive immunity: NKT cells induce B cell activation.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  Vaccine       Date:  2003-06-01       Impact factor: 3.641

Review 2.  The unconventional lifestyle of NKT cells.

Authors:  Mitchell Kronenberg; Laurent Gapin
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

3.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

4.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  Signaling lymphocytic activation molecule-associated protein controls NKT cell functions.

Authors:  Brian Chung; Ala Aoukaty; Jan Dutz; Cox Terhorst; Rusung Tan
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

7.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells.

Authors:  N Kadowaki; S Antonenko; S Ho; M C Rissoan; V Soumelis; S A Porcelli; L L Lanier; Y J Liu
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

9.  Distinct functional lineages of human V(alpha)24 natural killer T cells.

Authors:  Peter T Lee; Kamel Benlagha; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

Authors:  Michela Locci; Elena Draghici; Francesco Marangoni; Marita Bosticardo; Marco Catucci; Alessandro Aiuti; Caterina Cancrini; Laszlo Marodi; Teresa Espanol; Robbert G M Bredius; Adrian J Thrasher; Ansgar Schulz; Jiri Litzman; Maria Grazia Roncarolo; Giulia Casorati; Paolo Dellabona; Anna Villa
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

View more
  11 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

Authors:  Karina I Carvalho; Karina M Melo; Fernanda R Bruno; Jennifer E Snyder-Cappione; Douglas F Nixon; Beatriz T Costa-Carvalho; Esper G Kallas
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

3.  Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels.

Authors:  K Kraljevic; S Wong; D A Fulcher
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

4.  Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

Authors:  Umaimainthan Palendira; Carol Low; Anna Chan; Andrew D Hislop; Edwin Ho; Tri Giang Phan; Elissa Deenick; Matthew C Cook; D Sean Riminton; Sharon Choo; Richard Loh; Frank Alvaro; Claire Booth; H Bobby Gaspar; Alessandro Moretta; Rajiv Khanna; Alan B Rickinson; Stuart G Tangye
Journal:  PLoS Biol       Date:  2011-11-01       Impact factor: 8.029

5.  Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency.

Authors:  Michael B Fischer; Wendelin Wolfram; Christoph J Binder; Georg A Böhmig; Markus Wahrmann; Martha M Eibl; Hermann M Wolf
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

6.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

Review 7.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

Review 8.  T-cell abnormalities in common variable immunodeficiency: the hidden defect.

Authors:  Gabriel K Wong; Aarnoud P Huissoon
Journal:  J Clin Pathol       Date:  2016-05-06       Impact factor: 3.411

9.  Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.

Authors:  Dominic Paquin-Proulx; Nathália Silveira Barsotti; Bianca A N Santos; Ana Karolina B B Marinho; Cristina M Kokron; Karina I Carvalho; Myrthes T Barros; Jorge Kalil; Douglas F Nixon; Esper G Kallas
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults.

Authors:  Marie-Quitterie Picat; Rodolphe Thiébaut; François Lifermann; Xavier Delbrel; Daniel Adoue; Linda Wittkop; Anne-Laure Fauchais; Patrick Rispal; Jean-François Moreau; Jean-François Viallard
Journal:  BMC Immunol       Date:  2014-03-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.